Updated Jul 16, 2026
SLONIN JONATHAN has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $74K.
Jonathan Slonin serves as the Chief Medical Officer at Pacira BioSciences, Inc., a company focused on non-opioid pain management solutions. His role involves overseeing clinical development and medical affairs related to the company's product offerings.
| Role | Chief Medical Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-05 | PCRX | Pacira BioSciences, Inc. | F — Tax withholding / forfeiture | 4.7K | $22.32 | $106K |
| 2026-03-19 | PCRX | Pacira BioSciences, Inc. | S — Open-market sale [10b5-1] | 3.3K | $22.82 | $74K |
| 2026-02-13 | PCRX | Pacira BioSciences, Inc. | A — Grant or award | 54.5K | $0.00 | |
| 2026-02-03 | PCRX | Pacira BioSciences, Inc. | F — Tax withholding / forfeiture | 6.2K | $20.54 | $127K |
| 2025-08-01 | PCRX | Pacira BioSciences, Inc. | F — Tax withholding / forfeiture | 315 | $22.07 | $7K |
Jonathan Slonin serves as the Chief Medical Officer at Pacira BioSciences, Inc., a company focused on non-opioid pain management solutions. His role involves overseeing clinical development and medical affairs related to the company's product offerings.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($74K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live SLONIN JONATHAN profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.